Aura Biosciences, Inc.

AURA·NasdaqGM·Healthcare
Compare
6.65+0.41 (+6.57%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close6.24
Open6.42
Day range6.266.66
52-week range4.739.54
Off day high−0.15%
Off 52-week high−30.26%
Volume1.00M
Avg. volume (3M)890.22K
Market cap689.64M
EPS (TTM)-1.75
Forward P/E-3.28
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.44
Shares outstanding103.70M
Short interest10.57% of float
Earnings dateAug 11, 2026 (est.)
Analyst target16.60
Profit margin0.00%

Against its peers

Compare in full ›
AURA AVCT.L CADL PBYI 0RC6.IL IDYA
Market cap 689.64M 249.21M 692.49M 551.82M 1.22B 3.13B
P/E (TTM) — — — 21.0 60.6 —
Forward P/E -3.3 -21.1 -14.5 30.5 — -7.9
Price/book 2.2 71.2 5.5 3.9 5.8 2.9
Dividend yield — — — — 2.09% —
1-year change +22.92% −21.23% +83.20% +118.16% −8.11% +8.41%
Today +6.57% −0.97% +2.61% +4.60% +1.58% +3.29%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All AURA news ›

From the 4Search news index, newest first.

In the news

1mentions in 30 days
1with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance